TRNS Transcat
Transcat earnings company data as of 10:00 AM ET 10/23
Scheduled
1 period, newest first, nothing reported yet. Each row shows EPS above revenue.
| Period | Date | Metric | Estimate | Actual | Result |
|---|---|---|---|---|---|
| FY2026 Q3 | 3 Nov | EPS | 0.41 | — | — |
| Rev | — | — | — |
Insider trades
Open-market buys and sales by TRNS's executives, directors and 10% owners in the last 12 months, from their Form 4s
- $99K bought by 1 insider
- $673K sold by 2 insiders outside a trading plan
- None no planned (10b5-1) sales
-
Oksana S. Dominach DirectorSale$626K 7,312 shares at $85.60 63% of stakeTraded Sep 2 Filed Sep 3
-
Christopher P. Gillette DirectorSale$47K 504 shares at $94.23 72% of stakeTraded Aug 7 Filed Aug 12
-
Craig D. Cairns DirectorBuy$99K 1,050 shares at $93.97 +244% to stakeTraded Aug 6 Filed Aug 10
Also filed in the last 12 months, not counted as buying or selling: 18 option exercises, 12 share withholdings for taxes, and 3 stock grants.
SEC filings
Recent issuer filings from EDGAR, 17 shown.
| Filed | Form | Detail | Links |
|---|---|---|---|
| 8-K | 5.07 | Filing Doc | |
| 8-K | 2.02,9.01 | Filing Doc | |
| 10-Q | Filing Doc | ||
| DEF 14A | Filing Doc | ||
| DEFA14A | DEFA 14A | Filing Doc | |
| SCHEDULE 13G/A | — | Filing Doc | |
| 10-K | FORM 10-K | Filing Doc | |
| 8-K | 2.02,9.01 | Filing Doc | |
| 8-K | 5.02 | Filing Doc | |
| SCHEDULE 13G | — | Filing Doc | |
| SCHEDULE 13G | — | Filing Doc | |
| SCHEDULE 13G | — | Filing Doc | |
| SCHEDULE 13G/A | — | Filing Doc | |
| 8-K | 1.01,5.02,7.01,9.01 | Filing Doc | |
| SCHEDULE 13G/A | — | Filing Doc | |
| SCHEDULE 13G/A | — | Filing Doc | |
| SCHEDULE 13G | — | Filing Doc |
No filings match this filter.
Estimates are consensus figures; SEC filings remain the official record. Not investment advice.